CN104306963B - 一种猪丹毒活疫苗的生产方法 - Google Patents
一种猪丹毒活疫苗的生产方法 Download PDFInfo
- Publication number
- CN104306963B CN104306963B CN201410602361.3A CN201410602361A CN104306963B CN 104306963 B CN104306963 B CN 104306963B CN 201410602361 A CN201410602361 A CN 201410602361A CN 104306963 B CN104306963 B CN 104306963B
- Authority
- CN
- China
- Prior art keywords
- freeze
- strain
- vaccine
- live vaccine
- injection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229960005486 vaccine Drugs 0.000 title claims abstract description 101
- 201000000297 Erysipelas Diseases 0.000 title claims abstract description 32
- 238000004519 manufacturing process Methods 0.000 title claims description 8
- 241000186810 Erysipelothrix rhusiopathiae Species 0.000 claims abstract description 47
- 238000000034 method Methods 0.000 claims abstract description 44
- 230000000694 effects Effects 0.000 claims abstract description 14
- 238000003860 storage Methods 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 26
- 239000008215 water for injection Substances 0.000 claims description 25
- 229920002307 Dextran Polymers 0.000 claims description 19
- 230000001681 protective effect Effects 0.000 claims description 16
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 13
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 13
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 13
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 13
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 11
- 239000008103 glucose Substances 0.000 claims description 11
- 239000000413 hydrolysate Substances 0.000 claims description 11
- 239000001888 Peptone Substances 0.000 claims description 9
- 108010080698 Peptones Proteins 0.000 claims description 9
- 235000019319 peptone Nutrition 0.000 claims description 9
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 8
- 239000011734 sodium Substances 0.000 claims description 7
- 229910052708 sodium Inorganic materials 0.000 claims description 7
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 5
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 5
- 235000010469 Glycine max Nutrition 0.000 claims description 5
- 244000068988 Glycine max Species 0.000 claims description 5
- 229930195725 Mannitol Natural products 0.000 claims description 5
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 5
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 5
- 239000000594 mannitol Substances 0.000 claims description 5
- 235000010355 mannitol Nutrition 0.000 claims description 5
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 5
- 229920000053 polysorbate 80 Polymers 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 4
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 4
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 4
- 241000894006 Bacteria Species 0.000 abstract description 68
- 238000004108 freeze drying Methods 0.000 abstract description 35
- 241000282898 Sus scrofa Species 0.000 abstract description 31
- 230000008569 process Effects 0.000 abstract description 9
- 238000013461 design Methods 0.000 abstract description 8
- 238000009395 breeding Methods 0.000 abstract description 6
- 230000001488 breeding effect Effects 0.000 abstract description 6
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 5
- 239000000463 material Substances 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 3
- 241000282894 Sus scrofa domesticus Species 0.000 abstract description 2
- 235000015278 beef Nutrition 0.000 abstract description 2
- 241000699670 Mus sp. Species 0.000 description 49
- 239000003223 protective agent Substances 0.000 description 41
- 239000007788 liquid Substances 0.000 description 33
- 238000012360 testing method Methods 0.000 description 33
- 238000007689 inspection Methods 0.000 description 29
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 27
- 239000002609 medium Substances 0.000 description 24
- 238000010254 subcutaneous injection Methods 0.000 description 24
- 239000007929 subcutaneous injection Substances 0.000 description 24
- 239000000243 solution Substances 0.000 description 23
- 230000001954 sterilising effect Effects 0.000 description 22
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 20
- 229930006000 Sucrose Natural products 0.000 description 20
- 239000005720 sucrose Substances 0.000 description 20
- 238000002360 preparation method Methods 0.000 description 15
- 238000000151 deposition Methods 0.000 description 12
- 229920001817 Agar Polymers 0.000 description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 11
- 239000008272 agar Substances 0.000 description 11
- 230000037396 body weight Effects 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 108010010803 Gelatin Proteins 0.000 description 10
- 230000032683 aging Effects 0.000 description 10
- 230000001580 bacterial effect Effects 0.000 description 10
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 10
- 239000008273 gelatin Substances 0.000 description 10
- 229920000159 gelatin Polymers 0.000 description 10
- 235000019322 gelatine Nutrition 0.000 description 10
- 235000011852 gelatine desserts Nutrition 0.000 description 10
- 235000013923 monosodium glutamate Nutrition 0.000 description 10
- 238000004321 preservation Methods 0.000 description 10
- 229940073490 sodium glutamate Drugs 0.000 description 10
- 238000010257 thawing Methods 0.000 description 10
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 9
- 239000003814 drug Substances 0.000 description 9
- 238000002347 injection Methods 0.000 description 9
- 239000007924 injection Substances 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 9
- 235000013372 meat Nutrition 0.000 description 9
- 239000012528 membrane Substances 0.000 description 9
- 239000000600 sorbitol Substances 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 9
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 8
- 238000010790 dilution Methods 0.000 description 8
- 239000012895 dilution Substances 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- 238000005070 sampling Methods 0.000 description 8
- 235000014347 soups Nutrition 0.000 description 8
- 238000012795 verification Methods 0.000 description 8
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 7
- 229910052782 aluminium Inorganic materials 0.000 description 7
- 239000004411 aluminium Substances 0.000 description 7
- 239000003292 glue Substances 0.000 description 7
- 244000005700 microbiome Species 0.000 description 7
- 239000000758 substrate Substances 0.000 description 7
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 230000029087 digestion Effects 0.000 description 6
- 239000001963 growth medium Substances 0.000 description 6
- 238000011081 inoculation Methods 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 238000004659 sterilization and disinfection Methods 0.000 description 6
- 239000003085 diluting agent Substances 0.000 description 5
- 238000005304 joining Methods 0.000 description 5
- 230000004083 survival effect Effects 0.000 description 5
- 238000003556 assay Methods 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 239000013642 negative control Substances 0.000 description 4
- 239000002574 poison Substances 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 108010009736 Protein Hydrolysates Proteins 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 239000002518 antifoaming agent Substances 0.000 description 3
- 238000004500 asepsis Methods 0.000 description 3
- 238000000205 computational method Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 230000005847 immunogenicity Effects 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 238000009413 insulation Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000013049 sediment Substances 0.000 description 3
- 239000011265 semifinished product Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
- 101710194807 Protective antigen Proteins 0.000 description 2
- 102000013275 Somatomedins Human genes 0.000 description 2
- SMYKVLBUSSNXMV-UHFFFAOYSA-K aluminum;trihydroxide;hydrate Chemical compound O.[OH-].[OH-].[OH-].[Al+3] SMYKVLBUSSNXMV-UHFFFAOYSA-K 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229960000074 biopharmaceutical Drugs 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000005336 cracking Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 231100000518 lethal Toxicity 0.000 description 2
- 230000001665 lethal effect Effects 0.000 description 2
- 239000012533 medium component Substances 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 239000011814 protection agent Substances 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000273 veterinary drug Substances 0.000 description 2
- 241000589220 Acetobacter Species 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 206010015856 Extrasystoles Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 208000024949 Swine Erysipelas Diseases 0.000 description 1
- 108010003533 Viral Envelope Proteins Proteins 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000005138 cryopreservation Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108010009004 proteose-peptone Proteins 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 206010048282 zoonosis Diseases 0.000 description 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410602361.3A CN104306963B (zh) | 2014-10-31 | 2014-10-31 | 一种猪丹毒活疫苗的生产方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410602361.3A CN104306963B (zh) | 2014-10-31 | 2014-10-31 | 一种猪丹毒活疫苗的生产方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104306963A CN104306963A (zh) | 2015-01-28 |
CN104306963B true CN104306963B (zh) | 2016-02-03 |
Family
ID=52362372
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410602361.3A Active CN104306963B (zh) | 2014-10-31 | 2014-10-31 | 一种猪丹毒活疫苗的生产方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104306963B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104840955B (zh) * | 2015-06-16 | 2017-11-21 | 中国兽医药品监察所 | 一种布鲁氏菌活疫苗的生产方法 |
CN106755273A (zh) * | 2017-03-24 | 2017-05-31 | 广东温氏食品集团股份有限公司 | 一种检测猪瘟猪丹毒猪肺疫三联活疫苗抗原菌含量的选择性培养基及其制备方法和应用 |
CN110669684A (zh) * | 2018-09-20 | 2020-01-10 | 青岛高科技工业园海博生物技术有限公司 | 一种猪丹毒疫苗增菌培养基 |
CN112226379B (zh) * | 2019-12-26 | 2022-06-14 | 河南科技大学 | 猪红斑丹毒丝菌1a型菌株、猪丹毒灭活疫苗及其应用 |
CN114032199A (zh) * | 2021-11-30 | 2022-02-11 | 国药集团扬州威克生物工程有限公司 | 猪丹毒弱毒菌g4t10的增菌培养基、培养方法以及培养物的应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003264166A1 (en) * | 2002-09-23 | 2004-04-08 | Pfizer Products Inc. | Improvements in or relating to vaccines |
AU2002951692A0 (en) * | 2002-09-23 | 2002-10-17 | Vital Biotech (Hong Kong) Limited | Improvements in or relating to vaccines |
CN101926987B (zh) * | 2010-08-17 | 2012-05-23 | 北京中海生物科技有限公司 | 一种用合成培养基生产仔猪副伤寒活疫苗的方法 |
-
2014
- 2014-10-31 CN CN201410602361.3A patent/CN104306963B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN104306963A (zh) | 2015-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104306963B (zh) | 一种猪丹毒活疫苗的生产方法 | |
CN106479924B (zh) | 一种丁酸梭菌和丁酸梭菌活菌制剂的制备及应用 | |
CN102166362B (zh) | 猪繁殖与呼吸综合征活疫苗耐热冻干保护剂及制备方法 | |
CN103981139B (zh) | 一株布鲁氏菌弱毒株及其疫苗 | |
CN108904796B (zh) | 兔出血症病毒杆状病毒载体、多杀性巴氏杆菌病二联灭活疫苗及其制备方法 | |
CN102657870A (zh) | 一种无明胶及人血蛋白成分的疫苗冻干保护剂 | |
CN101912608B (zh) | 一种仔猪副伤寒活疫苗的生产方法 | |
CN103060220A (zh) | 一种低血清高效培养猪肺炎支原体培养基及其制备方法 | |
CN105816868A (zh) | 一种鸡滑液囊支原体灭活疫苗 | |
CN104845916B (zh) | 一株粗糙型羊种布鲁氏菌弱毒株及其疫苗 | |
CN104498441A (zh) | 鸭甲肝病毒iii型弱毒株及由其制备的活疫苗和应用 | |
CN105733987A (zh) | 一种鸡滑液囊支原体 | |
CN101926987B (zh) | 一种用合成培养基生产仔猪副伤寒活疫苗的方法 | |
CN105999281A (zh) | 禽类活病毒用冻干保护剂、制备方法及应用 | |
CN101745105B (zh) | 猪链球菌病、多杀性巴氏杆菌病灭活疫苗及其制备方法 | |
CN101766814A (zh) | 猪巴氏杆菌病二价灭活疫苗及其制备方法 | |
CN106512017A (zh) | 用于猪支原体肺炎活疫苗耐热保护剂及其制备方法和应用 | |
TWI325890B (zh) | ||
CN102851340A (zh) | 一种高效鸡基因工程鸡干扰素α的制备方法 | |
CN102292432A (zh) | 鸡败血支原体制剂 | |
CN103977400A (zh) | 一种用细胞系生产鸡马立克氏病活疫苗的方法 | |
CN104099269A (zh) | 猪肺炎支原体强毒株及其应用 | |
CN105031636B (zh) | 一种嗜水气单胞菌及维氏气单胞菌二联灭活疫苗及制备方法 | |
CN103800899B (zh) | 一种奶牛乳房炎疫苗 | |
CN109652344A (zh) | 菌株及其应用,以及疫苗及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160310 Address after: 100081 Beijing, Zhongguancun, South Street, No. 8, No. Patentee after: BEIJING ZHONGHAI BIOTECH Co.,Ltd. Patentee after: Tangshan Yi'an Biological Engineering Co.,Ltd. Address before: 100081 Beijing, Zhongguancun, South Street, No. 8, No. Patentee before: BEIJING ZHONGHAI BIOTECH Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240105 Address after: 100081 No. 8 South Main Street, Haidian District, Beijing, Zhongguancun Patentee after: BEIJING ZHONGHAI BIOTECH Co.,Ltd. Address before: 100081 No. 8 South Main Street, Haidian District, Beijing, Zhongguancun Patentee before: BEIJING ZHONGHAI BIOTECH Co.,Ltd. Patentee before: Tangshan Yi'an Biological Engineering Co.,Ltd. |